Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Pfizer withdraws sickle cell drug Oxbryta
Pfizer Sickle Cell Drug Suspended by Europe in New Setback
European regulators suspended the approval of Pfizer Inc.’s sickle cell anemia drug, Oxbryta, citing a higher rate of disease complications in patients who started taking the drug.The move comes less than a day after Pfizer abruptly announced a worldwide withdrawal of the drug,
Pfizer withdraws sickle cell disease treatment on risk of complication, death
U.S. drugmaker Pfizer said on Wednesday it was withdrawing its sickle cell disease treatment Oxbryta from all markets where it is approved, citing risks of a painful complication and deaths.
Sickle Cell Disease Drug Pulled From Global Markets
Pfizer is pulling its sickle cell disease (SCD) treatment voxelotor (Oxbryta) from global markets after data review showed an imbalance in deaths among patients taking the drug.
12h
on MSN
Pfizer's Oxbryta exit may hasten trials of rival experimental sickle cell drugs, analysts say
Pfizer's decision late on Wednesday to withdraw its sickle cell disease treatment due to the risk of death could help speed ...
The Business Journals
1d
Deaths lead Pfizer to pull sickle cell drug at center of $5 billion Bay Area buyout
The introduction of an FDA-approved drug didn't turn out the way buyer or seller hoped. Pfizer Inc. is pulling the
sickle
...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Trending now
Counselor accused of assault
Seeks dismissal of charges
Stadiums to serve as shelters
Military recruiting rebounds
Kotb leaving 'Today'
Chinese submarine sank
Settles defamation lawsuit
$8B military aid for Ukraine
NC board removes 747K
Urgent safety alert for 737s
To withdraw sickle cell drug
RU hits Ukraine's power grid
Targeted Black residents?
Boxes to distribute Narcan
ISR rejects ceasefire talks
Arrives in Luxembourg
Rose announces retirement
Weekly jobless claims fall
Capital goods orders up
On active shooter drills
Disbarred in DC
US economy grew
Jan. 6 report delayed
WI duplicate ballot flap
US suicides steady, high
NIH finds misconduct
On Secret Service failures
More executives leave
50/50 ball ownership suit
Password-sharing crackdown
Feedback